id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0242-0004,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice for Positron Emission Tomography Drugs",Notice,General Notice,2013-07-18T04:00:00Z,2013,7,2013-07-18T04:00:00Z,,2015-12-21T17:11:37Z,2013-17213,0,0,090000648136d4cb
FDA-2013-N-0242-0001,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice for Positron Emission Tomography Drugs",Notice,60 Day Proposed Information Collection,2013-03-20T04:00:00Z,2013,3,2013-03-20T04:00:00Z,2013-05-21T03:59:59Z,2015-12-21T17:10:36Z,2013-06351,0,0,09000064812374da